Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Timolol for Superficial Infantile Hemangioma
NCT02731287Phase 2Completed
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Mar 2014
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in infantile hemangioma (IH) comparing Timolol Arm with Placebo Arm (2 arms). Primary endpoint: Complete or almost complete resolution of the lesions at 24 weeks. Started Mar 2014; status: completed.
02
Drugs
timolol
03
Conditions
infantile hemangioma (IH)
Beyond the preview
Go deeper on NCT02731287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02731287.